See All Slides - tctmd.com

Slides

Presentation TCT 2012

ELM Presentation(4)

Presenter: Allen Jeremias

October 23, 2012

Presentation TCT 2012

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

Case 4: During Carotid Artery Stenting: Extracerebral or Access Vessel Related

Presenter: Fayaz Shawl

October 23, 2012

Presentation TCT 2012

Sirolimus-Eluting Stent (Svelte Medical) Program Update

Presenter: Mark Webster

October 23, 2012

Presentation TCT 2012

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

ELM Presentation(9)

Presenter: Jennifer Tremmel

October 23, 2012

Presentation TCT 2012

History of SCAI and CCI

Presenter: Frank Hildner

October 23, 2012

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Pro!

Presenter: Mehdi Shishehbor

October 23, 2012

Presentation TCT 2012

TCT-92. Does Mitral Regurgitation Impact the Outcome of TAVI Procedures? Insights from the FRANCE2 Registry

Presenter: Eric van Belle

October 23, 2012

Presentation TCT 2012

When Should MVD be Managed Medically?

Presenter: William Boden

October 23, 2012

Advertisement

Slides

ELM Presentation(4)

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Case 4: During Carotid Artery Stenting: Extracerebral or Access Vessel Related

Sirolimus-Eluting Stent (Svelte Medical) Program Update

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

ELM Presentation(9)

History of SCAI and CCI

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Pro!

TCT-92. Does Mitral Regurgitation Impact the Outcome of TAVI Procedures? Insights from the FRANCE2 Registry

When Should MVD be Managed Medically?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content